SCHEMBL6186894

SCHEMBL6186894

COc1cccc(OC)c1C(=O)c1c(C)[nH]c2ccc(NC(=O)c3cccnc3)cc12

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.55
TSHR P16473 2/20 0.55
RAB9A P51151 2/20 0.50
MAPT P10636 3/20 0.49
HTT P42858 1/20 0.48
NPC1 O15118 1/20 0.47
ALDH1A1 P00352 3/20 0.47
GAA P10253 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2C9 P11712 1/20 0.47
KMT2A Q03164 1/20 0.47
ABCG2 Q9UNQ0 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
KCNK3 O14649 1/20 0.47
POLB P06746 1/20 0.46
KDM4E B2RXH2 2/20 0.46
LMNA P02545 1/20 0.46
MAPK1 P28482 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6188852 0.87 RAB9A (0.55) SMN1; SMN2TSHRRAB9AMAPTHTT
SCHEMBL6185392 0.76 MAOA (0.49) SMN1; SMN2ALDH1A1POLB
SCHEMBL6187015 0.76 ULK1 (0.49) SMN1; SMN2POLB
SCHEMBL6991349 0.75 SMN1; SMN2 (0.52) SMN1; SMN2TSHRRAB9AMAPTHTT
SCHEMBL6188508 0.75 MAOA (0.51) SMN1; SMN2RAB9ANPC1ALDH1A1CYP1A2
SCHEMBL7141202 0.73 HTR1F (0.69) SMN1; SMN2RAB9AMAPTNPC1ALDH1A1
SCHEMBL6191071 0.73 TUBB1 (0.44) TSHRRAB9AMAPTNPC1ALDH1A1
SCHEMBL4653584 0.72 SMN1; SMN2 (1.00) SMN1; SMN2TSHRRAB9AHTTNPC1
SCHEMBL6189495 0.72 PARP1 (0.45) RAB9AMAPTNPC1ALDH1A1KMT2A
SCHEMBL6481723 0.72 SMN1; SMN2 (0.55) SMN1; SMN2TSHRRAB9AMAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1554271-A1 SUBSTITUTED INDOLES AND THEIR USE AS HCV INHIBITORS Rigel Pharmaceuticals, Inc. (US) 2005-07-20 EP disclosed
WO-2004035571-A1 SUBSTITUTED INDOLES AND THEIR USE AS HCV INHIBITORS RIGEL PHARMACEUTICALS, INC. (US) 2004-04-29 WO disclosed